Harvest One Cannabis Inc. through its wholly-owned subsidiary Satipharm Ltd. has entered into an agreement to become a supplier to the renowned medicinal cannabis wholesale & distribution business, Health House International Pty Ltd.

Under the terms of the agreement, Harvest One will supply Health House with Satipharm CBD 50mg Gelpell® capsules. The product will continue its availability in Australia, while expanding distribution to New Zealand and Asia where and when legal.

Under the agreement, Health House will purchase in bulk and distribute Satipharm's medicinal cannabis products to their existing network of pharmacies while also supporting healthcare professionals with Satipharm product information. Health House International is one of the major wholesalers to Australian pharmacies for medicinal cannabis. In May 2017they imported one of the first legal international medicinal cannabis shipments into Australia. 

Satipharm CEO Jonathan Hartshorn commented: "This agreement with Health House increases the availability of our Satipharm CBD 50mg Gelpell® capsules across Australia, while expanding Satipharm's medical cannabis distribution territories to New Zealand and Asia. We are committed to delivering the highest quality cannabinoid-based products globally. As further regions become available, we will continue to put agreements in place that will allow us to meet the needs of our patients."